: Extensively Drug-Resistant Tuberculosis (XDR-TB) is a new challenge for Tuberculosis control programs. Lack of effective drugs and high rate of failure in treatment and mortality is a major threat for public health. Treatment of this serious infection needs well-designed individualized dosage regimen and powerful national TB program. In this review we will describe the XDR-TB definition and its epidemiology and will discuss about the treatment options and future opportunities.
No takes yet. Share an insight, caveat, or question.
Tabarsi et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: